Navigation Links
Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
Date:2/25/2013

tive conditions. These and other factors that may result in differences are discussed in greater detail in the Company's reports on Forms 10-K, 10-Q, and other filings with the Securities and Exchange Commission.

 Halozyme Therapeutics, Inc.Unaudited Condensed Consolidated Statements of OperationsThree Months EndedTwelve Months EndedDecember 31, December 31, 2012201120122011REVENUES:Product sales, net

$   1,459,735$
348,280$
2,887,442$
,836,102Revenues under collaborative agreements

20,333,8142,062,88639,437,78454,250,334Total revenues

21,793,5492,411,16642,325,22656,086,436OPERATING EXPENSES:Cost of product sales

653,88456,1591,094,400257,834Research and development

18,567,74414,916,20570,044,07357,563,470Selling, general and administrative

6,979,0345,866,92124,812,19918,104,073Total operating expenses

26,200,66220,839,28595,950,67275,925,377OPERATING LOSS

(4,407,113)(18,428,119)(53,625,446)(19,838,941)Interest and other income, net

1,25712,50473,44469,090NET LOSS

$ (4,405,856)$ (18,415,615)$ (53,552,002)$ (19,769,851)Basic and diluted net loss per share

$
(0.04)$
(0.18)$
(0.48)$
(0.19)Shares used in computing basic and diluted   net loss per share

112,323,056103,406,407111,077,105102,566,089 Halozyme Therapeutics, Inc.Unaudited Condensed Consolidated Balance SheetsDecember 31,December 31,20122011ASSETSCurrent assets:Cash and cash equivalents

$   99,901,264$   52,825,527Accounts receivable, net

15,703,0872,262,465Inventories

2,670,696567,263Prepaid expenses and other assets

12,752,8888,332,242Total current assets

131,027,93563,987,497Property and equipment, net

3,700,4621,771,048Total Assets

$ 134,728,397$   65,758,545LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable 

$
2,271,
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
2. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
3. Halozyme to Host Third Quarter Financial Results Conference Call
4. Halozyme Reports Second Quarter 2012 Financial Results
5. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
6. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
7. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
8. Halozyme Reports First Quarter 2012 Financial Results
9. Halozyme to Host First Quarter 2012 Financial Results Conference Call
10. Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
11. Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Research and Markets  has announced the addition of ... to their offering. This newly published ... publication available covering the neurotechnology industry. The report takes ... growth rates in four key segments of the neurotechnology ... the number of systems to be sold, worldwide revenue, ...
(Date:9/22/2014)... , Sept. 22, 2014 Children,s National ... Monday, Sept. 29 at 5 p.m. EDT for ... competition, in response to continued strong interest from ... each will be awarded to the winning presentations ... Innovation Symposium hosted by Children,s National in October. ...
(Date:9/22/2014)... 2014 Decision Resources Group finds that by the ... be worth $2 billion (U.S. dollars), increasing at a compound ... years (to 2018). This growth comes as Chile ... and 4.9 percent expected over the next three to five ... but highly competitive. The pharmaceutical market is dominated by prescription ...
Breaking Medicine Technology:The Market for Neurotechnology: 2014-2018 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 2Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 3
(Date:9/22/2014)... anxiety, excessive perspiration these symptoms are a few ... the body,s heart rate and plays a crucial role ... from Tel Aviv University points to an additional complication ... published in Mammalian Genome , was conducted by ... the Department of Human Molecular Genetics and Biochemistry at ...
(Date:9/22/2014)... (Washington) The efforts and leadership of Senators ... ensure access to vital primary care services were ... (ACP) and 20 other organizations, representing internal medicine ... the senators applauds them for introducing the Ensuring ... Act, S. 2694, which will extend current-law payment ...
(Date:9/22/2014)... Riverside is one of 11 collaborating institutions that have ... National Science Foundation for a project ... that include plant symbionts, animal and human pathogens and ... Zygomycetes, used in numerous industrial processes and fermentation of ... fungi. Symbiotic associations with zygomycetes may have facilitated the ...
(Date:9/22/2014)... Don Allred Insurance is pleased to announce ... NC. The satellite office, located in the Holly Hill Mall ... 2014, and offer all of the same professional services as ... Insurance spokesperson Scott Allred cites an expanding client base and ... of the major factors driving the decision to open a ...
(Date:9/22/2014)... California (PRWEB) September 22, 2014 ... care market occupies a significant presence in the ... most widespread healthcare problems globally. Key factors underlying ... lifestyle habits such as smoking; increasing levels of ... and expanding base of aging population vulnerable to ...
Breaking Medicine News(10 mins):Health News:Lack of thyroid hormone blocks hearing development 2Health News:Broad physician coalition urges Congress to extend Medicaid pay parity 2Health News:Project launched to study evolutionary history of fungi 2Health News:Project launched to study evolutionary history of fungi 3Health News:Project launched to study evolutionary history of fungi 4Health News:Allred Insurance to Open New Burlington Branch Office 2Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of Respiratory Diseases to Drive the Respiratory Care Equipment and Supplies Market, According to New Report by Global Industry Analysts, Inc. 4
... , , FREMONT, Calif., Nov. 24 ... today announced the launch of the VersaWave(R) Specialty Er:YAG all-issue dental ... Greater New York Dental Meeting, November 30 - December 3, 2008 ... , "The VersaWave Specialty builds on our solid heritage ...
... results yesterday evaluating the Novo-TTF device in vitro ... the device enhanced the efficacy of standard chemotherapy ... When used in combination with standard chemotherapy, the ... intensity alternating electric fields to destroy cancer cells, ...
... and Transportation System Reduces Endoscope Cross-contamination and Protects Scopes ... New Infection Prevention Solution for Busy GI Suites , ... 24 Advanced Sterilization Products (ASP), division of Ethicon ... CLEANASCOPE System, a new infection prevention solution designed to ...
... , , MONDAY, Nov. 24 (HealthDay News) -- The interaction between ... may contribute to epileptic seizures, new research suggests. , If ... be a target for new treatments or even preventive measures ... of Nature Medicine . , "This opens a window ...
... Recognized - , , WASHINGTON, Nov. ... definitive voice for 50+ Americans and the world,s largest-circulation magazine with ... Inspire Awards . The Inspire Awards pay tribute ... innovative thinking, passion and perseverance. The 2009 honorees include Glenn ...
... developer of,LifeShirt(R), a continuous, integrated and wearable remote ... proprietary LifeShirt(R),system is being used by Concordia ... factors that may put children at risk for ... Children enrolled in ...
Cached Medicine News:Health News:HOYA ConBio(TM) Introduces VersaWave(R) Specialty Laser 2Health News:Studies show novel device may enhance chemotherapy treatment in brain tumors 2Health News:Studies show novel device may enhance chemotherapy treatment in brain tumors 3Health News:ASP Announces Availability of CLEANASCOPE System 2Health News:Clue to Cause of Epileptic Seizures Discovered 2Health News:Glenn Close, Alma Powell, and Quincy Jones to Be Honored at AARP The Magazine's 2009 Inspire Awards 2Health News:Glenn Close, Alma Powell, and Quincy Jones to Be Honored at AARP The Magazine's 2009 Inspire Awards 3Health News:Glenn Close, Alma Powell, and Quincy Jones to Be Honored at AARP The Magazine's 2009 Inspire Awards 4Health News:Glenn Close, Alma Powell, and Quincy Jones to Be Honored at AARP The Magazine's 2009 Inspire Awards 5Health News:Glenn Close, Alma Powell, and Quincy Jones to Be Honored at AARP The Magazine's 2009 Inspire Awards 6Health News:Glenn Close, Alma Powell, and Quincy Jones to Be Honored at AARP The Magazine's 2009 Inspire Awards 7Health News:Glenn Close, Alma Powell, and Quincy Jones to Be Honored at AARP The Magazine's 2009 Inspire Awards 8Health News:VivoMetrics' LifeShirt(R) Selected by Concordia University to Provide Patient Data for Healthy Heart Research Project 2Health News:VivoMetrics' LifeShirt(R) Selected by Concordia University to Provide Patient Data for Healthy Heart Research Project 3Health News:VivoMetrics' LifeShirt(R) Selected by Concordia University to Provide Patient Data for Healthy Heart Research Project 4
The WADiana Compact is a fully automated immuno-haematology analyser, easy to use with maximum security including clot detection and ensuring no contamination....
... on patented microplate agglutination technology. Its is ... donor ABO/Rh testing. PK7200 also handles weak ... antibody detection. The Automated Microplate System delivers ... proven reliability that for the past generation ...
... Tecan Haemotyper is an automated ... The Tecan Haemotyper combines a ... platform with the DiaMed agglutination ... process DiaMed-ID cards and microplates ...
... Since the early 1990s, the "Reversed" ... shoulder surgeons with great success. More recently, ... United States have begun to champion this ... go with it. This reversed technology is ...
Medicine Products: